Zoetis Inc. Stock price

Equities

ZTS

US98978V1035

Pharmaceuticals

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT 5-day change 1st Jan Change
168.5 USD +1.71% Intraday chart for Zoetis Inc. -1.45% -14.62%
Sales 2024 * 9.18B Sales 2025 * 9.84B Capitalization 77.16B
Net income 2024 * 2.52B Net income 2025 * 2.75B EV / Sales 2024 * 8.87 x
Net Debt 2024 * 4.33B Net Debt 2025 * 3.83B EV / Sales 2025 * 8.23 x
P/E ratio 2024 *
30.9 x
P/E ratio 2025 *
27.8 x
Employees 14,100
Yield 2024 *
1.02%
Yield 2025 *
1.16%
Free-Float 91.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.71%
1 week-1.45%
Current month-15.04%
1 month-15.32%
3 months-14.42%
6 months-3.53%
Current year-14.62%
More quotes
1 week
164.11
Extreme 164.11
171.36
1 month
164.11
Extreme 164.11
200.53
Current year
164.11
Extreme 164.11
200.53
1 year
151.03
Extreme 151.03
201.92
3 years
124.15
Extreme 124.1483
249.27
5 years
90.14
Extreme 90.14
249.27
10 years
28.14
Extreme 28.135
249.27
More quotes
Managers TitleAgeSince
Chief Executive Officer 52 11-12-31
Director of Finance/CFO 52 21-05-31
Chief Tech/Sci/R&D Officer - 10-12-31
Members of the board TitleAgeSince
Chairman 71 12-12-31
Director/Board Member 73 13-07-31
Director/Board Member 74 13-05-31
More insiders
Date Price Change Volume
24-03-27 168.5 +1.71% 2,857,848
24-03-26 165.7 -1.28% 4,550,016
24-03-25 167.8 -0.65% 2,762,325
24-03-22 168.9 +0.34% 2,840,485
24-03-21 168.3 -1.56% 4,400,860

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (64.4%): cats and dogs (94.9% of net sales) and horses (5.1%); - livestock (34.5%): cattle (51.6% of sales), swine (20.2%), poultry (17.1%), fish (7.6%) and other (3.5%); - other (1.1%). Net sales break down by family of products into parasiticides (23%), vaccines (21.3%), dermatological products (16.4%), anti-infectives (13.4%), medical food additives (4.5%), diagnostic products (4.4%) and other (17%). At the end of 2022, the group has 29 production sites worldwide. The United States accounts for 53.4% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
168.5 USD
Average target price
221.9 USD
Spread / Average Target
+31.70%
Consensus
  1. Stock
  2. Equities
  3. Stock Zoetis Inc. - Nyse